Click Here for 5% Off Your First Aladdin Purchase!

Nicotinic acid - for cell culture, for insect cell culture,≥99%, high purity , CAS No.59-67-6

  • for cell culture
  • for insect cell culture
  • Moligand™
  • ≥99%
Item Number
N118655
Grouped product items
SKUSizeAvailabilityPrice Qty
N118655-100g
100g
In stock
$30.90
N118655-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$136.90
View related series
Spectroscopic reagent

Basic Description

Synonymsnicotinic acid|niacin|59-67-6|Pyridine-3-carboxylic acid|3-pyridinecarboxylic acid|vitamin B3|3-Carboxypyridine|wampocap|Niaspan|Acidum nicotinicum|nicolar|Apelagrin|Pellagrin|Akotin|Daskil|Efacin|Pelonin|Linic|nicamin|nicobid|nicocap|Enduracin|Nicodelmin
Specifications & PurityMoligand™, for cell culture, for insect cell culture, ≥99%
Storage TempProtected from light
Shipped InNormal
Gradefor cell culture, for insect cell culture, Moligand™

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD2 Tclin D(2) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD4 Tchem D(4) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ELANE Tclin Neutrophil elastase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EGFR Tclin Epidermal growth factor receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH1 Tclin Histamine H1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CA2 Tclin Carbonic anhydrase 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

XDH Tclin Xanthine dehydrogenase/oxidase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM4 Tclin Muscarinic acetylcholine receptor M4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2B Tclin Alpha-2B adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2C Tclin Alpha-2C adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2A Tclin 5-hydroxytryptamine receptor 2A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA2A Tclin Adenosine receptor A2a 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ACHE Tclin Acetylcholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAOA Tclin Amine oxidase [flavin-containing] A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKR1B1 Tclin Aldose reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

APP Tclin Amyloid-beta A4 protein 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA1 Tclin Adenosine receptor A1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR3A Tclin 5-hydroxytryptamine receptor 3A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR6 Tchem 5-hydroxytryptamine receptor 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRA Tclin Endothelin-1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRB Tclin Endothelin receptor type B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRD1 Tclin Delta-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRK1 Tclin Kappa-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NOS2 Tchem Nitric oxide synthase, inducible 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TACR1 Tclin Substance-P receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NOS1 Tchem Nitric oxide synthase, brain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name pyridine-3-carboxylic acid
INCHI InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
InChi Key PVNIIMVLHYAWGP-UHFFFAOYSA-N
Canonical SMILES C1=CC(=CN=C1)C(=O)O
Isomeric SMILES C1=CC(=CN=C1)C(=O)O
RTECS QT0525000
Alternate CAS 59-67-6,99148-57-9 (tosylate)
PubChem CID 938
NSC Number 169454
MeSH Entry Terms 3 Pyridinecarboxylic Acid;3-Pyridinecarboxylic Acid;Aluminum Salt, Niacin;Enduracin;Hydrochloride, Niacin;Induracin;Lithium Nicotinate;Niacin;Niacin Aluminum Salt;Niacin Ammonium Salt;Niacin Calcium Salt;Niacin Cobalt (2+) Salt;Niacin Copper (2+) Salt;Nia
Molecular Weight 123.11
Beilstein 109591

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

8 results found

Lot NumberCertificate TypeDateItem
B2302534Certificate of AnalysisFeb 10, 2023 N118655
A2423022Certificate of AnalysisJul 03, 2022 N118655
D2321379Certificate of AnalysisJul 03, 2022 N118655
H2220323Certificate of AnalysisJul 03, 2022 N118655
H2220324Certificate of AnalysisJul 03, 2022 N118655
H2220325Certificate of AnalysisJul 03, 2022 N118655
H2412474Certificate of AnalysisJul 03, 2022 N118655
J2311072Certificate of AnalysisApr 25, 2021 N118655

Chemical and Physical Properties

SensitivityLight sensitive
Flash Point(°C)193°C
Melt Point(°C)238°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H319:Causes serious eye irritation

H412:Harmful to aquatic life with long lasting effects

Precautionary Statements

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P501:Dispose of contents/container to ...

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

RTECS QT0525000
Merck Index 6525

Related Documents

References

1. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S.  (2003)  PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect..  Nat Med,  (3): (352-5).  [PMID:12563315]
2. Richman JG, Kanemitsu-Parks M, Gaidarov I, Cameron JS, Griffin P, Zheng H, Guerra NC, Cham L, Maciejewski-Lenoir D, Behan DP et al..  (2007)  Nicotinic acid receptor agonists differentially activate downstream effectors..  J Biol Chem,  282  (25): (18028-36).  [PMID:17452318]
3. Jung JK, Johnson BR, Duong T, Decaire M, Uy J, Gharbaoui T, Boatman PD, Sage CR, Chen R, Richman JG et al..  (2007)  Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b..  J Med Chem,  50  (7): (1445-8).  [PMID:17358052]
4. Shen HC, Ding FX, Raghavan S, Deng Q, Luell S, Forrest MJ, Carballo-Jane E, Wilsie LC, Krsmanovic ML, Taggart AK et al..  (2010)  Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate..  J Med Chem,  53  (6): (2666-70).  [PMID:20184326]
5. Shen HC, Ding FX, Deng Q, Wilsie LC, Krsmanovic ML, Taggart AK, Carballo-Jane E, Ren N, Cai TQ, Wu TJ et al..  (2009)  Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats..  J Med Chem,  52  (8): (2587-602).  [PMID:19309152]
6. Imbriglio JE, Chang S, Liang R, Raghavan S, Schmidt D, Smenton A, Tria S, Schrader TO, Jung JK, Esser C et al..  (2010)  GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a..  Bioorg Med Chem Lett,  20  (15): (4472-4).  [PMID:20615702]
7. Skinner PJ, Webb PJ, Sage CR, Dang TH, Pride CC, Chen R, Tamura SY, Richman JG, Connolly DT, Semple G.  (2009)  5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b..  Bioorg Med Chem Lett,  19  (15): (4207-9).  [PMID:19524438]
8. J E Mrochek,R L Jolley,D S Young,W J Turner.  (1976-11-01)  Metabolic response of humans to ingestion of nicotinic acid and nicotinamide..  Clinical chemistry,  22  ((11)): (1821-1827).  [PMID:135660]
9. M R Stratford,M F Dennis,P Hoskin,H Phillips,R J Hodgkiss,A Rojas.  (1996-07-01)  Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring..  British journal of cancer,  74  ((1)): (16-21).  [PMID:8679452]
10. Arthur S Brecher,Mohammed T Adamu.  (2002-04-18)  Short- and long-term effects of acetaldehyde on plasma..  Alcohol (Fayetteville, N.Y.),  26  ((1)): (49-53).  [PMID:11958947]
11. Nicholas B Pike.  (2005-12-03)  Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid..  The Journal of clinical investigation,  115  ((12)): (3400-3403).  [PMID:16322787]
12. Raul D Santos.  (2006-01-10)  [Pharmacology of niacin or nicotinic acid]..  Arquivos brasileiros de cardiologia,  85 Suppl 5  (17-19).  [PMID:16400392]
13. Bram Baert,Eric Deconinck,Mireille Van Gele,Marian Slodicka,Paul Stoppie,Samuel Bodé,Guido Slegers,Yvan Vander Heyden,Jo Lambert,Johan Beetens,Bart De Spiegeleer.  (2007-09-11)  Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds..  Bioorganic & medicinal chemistry,  15  ((22)): (6943-6955).  [PMID:17827020]
14. Hong C Shen,Fa-Xiang Ding,Silvi Luell,Michael J Forrest,Ester Carballo-Jane,Kenneth K Wu,Tsuei-Ju Wu,Kang Cheng,Larissa C Wilsie,Mihajlo L Krsmanovic,Andrew K Taggart,Ning Ren,Tian-Quan Cai,Qiaolin Deng,Qing Chen,Junying Wang,Michael S Wolff,Xinchun Tong,Tom G Holt,M Gerard Waters,Milton L Hammond,James R Tata,Steven L Colletti.  (2007-11-13)  Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor..  Journal of medicinal chemistry,  50  ((25)): (6303-6306).  [PMID:17994679]
15. Vaijinath S Kamanna,Anthony Vo,Moti L Kashyap.  (2008-06-04)  Nicotinic acid: recent developments..  Current opinion in cardiology,  23  ((4)): (393-398).  [PMID:18520725]
16. Qiaolin Deng,Jessica L Frie,Daria M Marley,Richard T Beresis,Ning Ren,Tian-Quan Cai,Andrew K P Taggart,Kang Cheng,Ester Carballo-Jane,Junying Wang,Xinchun Tong,M Gerard Waters,James R Tata,Steven L Colletti.  (2008-09-02)  Molecular modeling aided design of nicotinic acid receptor GPR109A agonists..  Bioorganic & medicinal chemistry letters,  18  ((18)): (4963-4967).  [PMID:18760600]
17. H E Bays,D J Rader.  (2008-12-05)  Does nicotinic acid (niacin) lower blood pressure?.  International journal of clinical practice,  63  ((1)): (151-159).  [PMID:19054161]
18. Jason E Imbriglio,Sookhee Chang,Rui Liang,Subharekha Raghavan,Darby Schmidt,Abby Smenton,Scott Tria,Thomas O Schrader,Jae-Kyu Jung,Craig Esser,Andrew K P Taggart,Kang Cheng,Ester Carballo-Jane,M Gerard Waters,James R Tata,Steven L Colletti.  (2009-03-25)  GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a..  Bioorganic & medicinal chemistry letters,  19  ((8)): (2121-2124).  [PMID:19307116]
19. Janet E Digby,Justin M S Lee,Robin P Choudhury.  (2009-06-06)  Nicotinic acid and the prevention of coronary artery disease..  Current opinion in lipidology,  20  ((4)): (321-326).  [PMID:19494772]
20. Paul Martres.  (2009-06-13)  HM74a agonists: will they be the new generation of nicotinic acid?.  Current topics in medicinal chemistry,  ((5)): (428-435).  [PMID:19519459]
21. Caroline M Perry.  (2009-08-15)  Extended-release niacin (nicotinic acid)/laropiprant..  Drugs,  69  ((12)): (1665-1679).  [PMID:19678716]
22. Heinz Drexel.  (2009-08-18)  Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?.  Fundamental & clinical pharmacology,  23  ((6)): (687-692).  [PMID:19682084]
23. Darby Schmidt,Abigail Smenton,Subharekha Raghavan,Hong Shen,Fa-Xiang Ding,Ester Carballo-Jane,Silvi Luell,Tanya Ciecko,Tom G Holt,Michael Wolff,Andrew Taggart,Larissa Wilsie,Mihajlo Krsmanovic,Ning Ren,Daniel Blom,Kang Cheng,Peggy E McCann,M Gerard Waters,James Tata,Steven Colletti.  (2010-05-07)  Anthranilic acid replacements in a niacin receptor agonist..  Bioorganic & medicinal chemistry letters,  20  ((11)): (3426-3430).  [PMID:20444602]
24. Hans F N Kvitvang,Trygve Andreassen,Tomas Adam,Silas G Villas-Bôas,Per Bruheim.  (2011-03-11)  Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids..  Analytical chemistry,  83  ((7)): (2705-2711).  [PMID:21388201]
25. Minjun Chen,Vikrant Vijay,Qiang Shi,Zhichao Liu,Hong Fang,Weida Tong.  (2011-06-01)  FDA-approved drug labeling for the study of drug-induced liver injury..  Drug discovery today,  16  ((15-16)): (697-703).  [PMID:21624500]
26. Rachael Hartman,Taylor Defelice,Julia Tzu,Shane Meehan,Miguel Sanchez.  (2011-10-28)  Acanthosis nigricans in the setting of niacin therapy..  Dermatology online journal,  17  ((10)): (11-11).  [PMID:22031637]
27. Rahul Yadav,See Kwok,Basil J Ammori,Basil Issa,Handrean Soran.  (2011-12-03)  Safety and tolerability of extended-release niacin with laropiprant..  Expert opinion on drug safety,  11  ((1)): (151-159).  [PMID:22133050]
28. Andrew P Dunatchik,Matthew K Ito,Carlos A Dujovne.  (2012-03-06)  A systematic review on evidence of the effectiveness and\xa0safety of a wax-matrix niacin formulation..  Journal of clinical lipidology,  ((2)): (121-131).  [PMID:22385545]
29. Erin D Michos,Christopher T Sibley,Jefferson T Baer,Michael J Blaha,Roger S Blumenthal.  (2012-04-24)  Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials..  Journal of the American College of Cardiology,  59  ((23)): (2058-2064).  [PMID:22520249]
30. Tai-Heng Chen,Clement Mtika.  (2012-11-02)  The peeling dermatitis with a peculiar demarcation..  The American journal of the medical sciences,  346  ((5)): (421-421).  [PMID:23114198]
31. U Julius,S Fischer.  (2013-01-30)  Nicotinic acid as a lipid-modifying drug--a review..  Atherosclerosis. Supplements,  14  ((1)): (7-13).  [PMID:23357134]
32. Yu-Xian Chi,Hui-Ping Dai,Shu-Mei Li,Jing Jin,Shu-Yun Niu,Guang-Ning Zhang.  (2013-02-12)  Syntheses, crystal structures and photophysical properties of Ag(I) coordination complexes..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  106  (203-209).  [PMID:23396006]
33. Wanda C Lakey,Nicole Greyshock,John R Guyton.  (2013-02-19)  Adverse reactions of Achilles tendon xanthomas in three hypercholesterolemic patients after treatment intensification with niacin and bile acid sequestrants..  Journal of clinical lipidology,  ((2)): (178-181).  [PMID:23415439]
34. .  (2013-03-08)  Drugs for hypertriglyceridemia..  The Medical letter on drugs and therapeutics,  55  ((1411)): (17-19).  [PMID:23467119]
35. Tom Noff,Jerald Insel.  (2013-04-06)  Energy drinks and the unwanted buzz: a case report..  Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society,  13  ((4)): (28-29).  [PMID:23556369]
36. N Nakajima,M Ueda,N Higashi,Y Katayama.  (2013-05-07)  Erythromelalgia associated with Clitocybe acromelalga intoxication..  Clinical toxicology (Philadelphia, Pa.),  51  ((5)): (451-454).  [PMID:23641936]
37. Kambiz Zandi-Nejad,Ayumi Takakura,Mollie Jurewicz,Anil K Chandraker,Stefan Offermanns,David Mount,Reza Abdi.  (2013-07-25)  The role of HCA2 (GPR109A) in regulating macrophage function..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology,  27  ((11)): (4366-4374).  [PMID:23882124]
38. Joy Wahawisan,John M Tovar,Mark C Granberry.  (2013-12-18)  Statin therapy: when to think twice..  The Journal of family practice,  62  ((12)): (726-732).  [PMID:24340334]
39. Hans-Michael Wolff,Irsan,Kalliopi Dodou.  (2014-03-07)  Investigations on the viscoelastic performance of pressure sensitive adhesives in drug-in-adhesive type transdermal films..  Pharmaceutical research,  31  ((8)): (2186-2202).  [PMID:24599801]
40. Alberto Zambon,Xue-Qiao Zhao,B Greg Brown,John D Brunzell.  (2014-03-20)  Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease..  The American journal of cardiology,  113  ((9)): (1494-1498).  [PMID:24641964]
41. Julio V Suarez,Stephen Banks,Paul G Thomas,Anil Day.  (2014-06-18)  A new F131V mutation in Chlamydomonas phytoene desaturase locates a cluster of norflurazon resistance mutations near the FAD-binding site in 3D protein models..  PloS one,  ((6)): (e99894-e99894).  [PMID:24936791]
42. Maria Angela Guzzardi,Leanne Hodson,Letizia Guiducci,Elena Sanguinetti,Pietro Di Cecco,Tiziana Liistro,Cristina Vassalle,Silvia Pardini,Lucia Giorgetti,Piero A Salvadori,Silvia Burchielli,Patricia Iozzo.  (2014-06-26)  Independent effects of circulating glucose, insulin and NEFA on cardiac triacylglycerol accumulation and myocardial insulin resistance in a swine model..  Diabetologia,  57  ((9)): (1937-1946).  [PMID:24962669]
43. Sofia Tapani,Joachim Almquist,Jacob Leander,Christine Ahlström,Lambertus A Peletier,Mats Jirstrand,Johan Gabrielsson.  (2014-07-06)  Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid..  Journal of pharmaceutical sciences,  103  ((8)): (2571-2584).  [PMID:24986056]
44. Donald M Lloyd-Jones.  (2014-07-12)  Niacin and HDL cholesterol--time to face facts..  The New England journal of medicine,  371  ((3)): (271-273).  [PMID:25014692]
45. Daniel Keene,Clare Price,Matthew J Shun-Shin,Darrel P Francis.  (2014-07-20)  Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients..  BMJ (Clinical research ed.),  349  (g4379-g4379).  [PMID:25038074]
46. Michael McCarthy.  (2014-07-25)  Niacin fails to reduce vascular events in large randomised trial..  BMJ (Clinical research ed.),  349  (g4774-g4774).  [PMID:25055803]
47. Kristel Hälvin,Ildar Nisamedtinov,Toomas Paalme.  (2014-09-10)  Comparison of different extraction methods to determine free and bound forms of B-group vitamins in quinoa..  Analytical and bioanalytical chemistry,  406  ((28)): (7355-7366).  [PMID:25195054]
48. Mack Moyo,Stephen O Amoo,Adeyemi O Aremu,Jiří Gruz,Michaela Subrtová,Karel Doležal,Johannes Van Staden.  (2014-09-16)  Plant regeneration and biochemical accumulation of hydroxybenzoic and hydroxycinnamic acid derivatives in Hypoxis hemerocallidea organ and callus cultures..  Plant science : an international journal of experimental plant biology,  227  (157-164).  [PMID:25219317]
49. Anja Veronovski,Gabrijela Tkalec,Željko Knez,Zoran Novak.  (2014-09-27)  Characterisation of biodegradable pectin aerogels and their potential use as drug carriers..  Carbohydrate polymers,  113  (272-278).  [PMID:25256485]
50. K Maráková,J Piestanský,E Havránek,P Mikus.  (2014-10-03)  Simultaneous analysis of vitamins B in pharmaceuticals and dietary supplements by capillary electrophoresis hyphenated with triple quadrupole mass spectrometry..  Die Pharmazie,  69  ((9)): (663-668).  [PMID:25272936]
51. Robert T Burns,Jan A Pechenik,William J Biggers,Gia Scavo,Christopher Lehman.  (2014-11-13)  The B vitamins nicotinamide (B3) and riboflavin (B2) stimulate metamorphosis in larvae of the deposit-feeding polychaete Capitella teleta: implications for a sensory ligand-gated ion channel..  PloS one,  ((11)): (e109535-e109535).  [PMID:25390040]
52. Martin J Landray,Richard Haynes,Jane Armitage.  (2014-11-13)  Niacin for reduction of cardiovascular risk..  The New England journal of medicine,  371  ((20)): (1943-1944).  [PMID:25390748]
53. Christopher M Rembold.  (2014-11-13)  Niacin for reduction of cardiovascular risk..  The New England journal of medicine,  371  ((20)): (1940-1941).  [PMID:25390749]
54. Amit V Khera,Arman Qamar,Muredach P Reilly,Richard L Dunbar,Daniel J Rader.  (2014-11-30)  Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 levels in patients with dyslipidemia..  The American journal of cardiology,  115  ((2)): (178-182).  [PMID:25432415]
55. Brian M De Borba,Richard F Jack,Jeffrey S Rohrer,Joan Wirt,Dongmei Wang.  (2014-12-03)  Simultaneous determination of total nitrogen and total phosphorus in environmental waters using alkaline persulfate digestion and ion chromatography..  Journal of chromatography. A,  1369  (131-137).  [PMID:25441080]
56. Vladimir Tolstikov,Alexander Nikolayev,Sucai Dong,Genshi Zhao,Ming-Shang Kuo.  (2014-12-09)  Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells..  PloS one,  ((12)): (e114019-e114019).  [PMID:25486521]
57. Won Seok Yang,Hyun Woo Kim,Joo Mi Lee,Nam Jeong Han,Mee Jeong Lee,Su-Kil Park.  (2015-01-04)  1,25-dihydroxyvitamin D3 causes ADAM10-dependent ectodomain shedding of tumor necrosis factor receptor 1 in vascular smooth muscle cells..  Molecular pharmacology,  87  ((3)): (533-542).  [PMID:25556238]
58. Rohini Sidhu,Hui Jiang,Nicole Y Farhat,Nuria Carrillo-Carrasco,Myra Woolery,Elizabeth Ottinger,Forbes D Porter,Jean E Schaffer,Daniel S Ory,Xuntian Jiang.  (2015-04-14)  A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid..  Journal of lipid research,  56  ((6)): (1222-1233).  [PMID:25866316]
59. Miao Hu,Ya-Ling Yang,Chi-Fai Ng,Chui-Ping Lee,Vivian W Y Lee,Hiroyuki Hanada,Daisaku Masuda,Shizuya Yamashita,Brian Tomlinson.  (2015-05-23)  Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemia..  Medicine,  94  ((20)): (e881-e881).  [PMID:25997070]
60. Shobha H Ganji,Moti L Kashyap,Vaijinath S Kamanna.  (2015-05-31)  Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease..  Metabolism: clinical and experimental,  64  ((9)): (982-990).  [PMID:26024755]
61. Shuai Yang,Xitao Li,Nasui Wang,Guoshu Yin,Shuhua Ma,Yucai Fu,Chiju Wei,Yongsong Chen,Wencan Xu.  (2015-06-28)  GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation..  Annals of clinical and laboratory science,  45  ((3)): (315-322).  [PMID:26116596]
62. Rosamaria Lappano,Camillo Rosano,Assunta Pisano,Maria Francesca Santolla,Ernestina Marianna De Francesco,Paola De Marco,Vincenza Dolce,Marco Ponassi,Lamberto Felli,Grazia Cafeo,Franz Heinrich Kohnke,Sergio Abonante,Marcello Maggiolini.  (2015-07-18)  A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models..  Disease models & mechanisms,  ((10)): (1237-1246).  [PMID:26183213]
63. Kana Arai,Hiroyuki Terashima,Sen-ichi Aizawa,Atsushi Taga,Atsushi Yamamoto,Kaname Tsutsumiuchi,Shuji Kodama.  (2015-08-11)  Simultaneous Determination of Trigonelline, Caffeine, Chlorogenic Acid and Their Related Compounds in Instant Coffee Samples by HPLC Using an Acidic Mobile Phase Containing Octanesulfonate..  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry,  31  ((8)): (831-835).  [PMID:26256608]
64. Victoria G Pederick,Bart A Eijkelkamp,Stephanie L Begg,Miranda P Ween,Lauren J McAllister,James C Paton,Christopher A McDevitt.  (2015-08-21)  ZnuA and zinc homeostasis in Pseudomonas aeruginosa..  Scientific reports,  (13139-13139).  [PMID:26290475]
65. S I Chekalina,L I Guseva,M S Bardyechev.  (1985-08-01)  [Use of nicotinic acid and midocalm for correcting blood coagulation in patients with radiation edema of the extremities]..  Meditsinskaia radiologiia,  30  ((8)): (28-30).  [PMID:4033386]
66. Rahul Yadav,Michael France,Naveed Younis,Salam Hama,Basil J Ammori,See Kwok,Handrean Soran.  (2012-05-23)  Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety..  Expert opinion on pharmacotherapy,  13  ((9)): (1345-1362).  [PMID:22607011]
67. Paul M Lavigne,Richard H Karas.  (2012-12-26)  The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression..  Journal of the American College of Cardiology,  61  ((4)): (440-446).  [PMID:23265337]
68. Joshua T Chai,Janet E Digby,Robin P Choudhury.  (2013-03-26)  GPR109A and vascular inflammation..  Current atherosclerosis reports,  15  ((5)): (325-325).  [PMID:23526298]
69. Amit V Khera,Parin J Patel,Muredach P Reilly,Daniel J Rader.  (2013-08-13)  The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality..  Journal of the American College of Cardiology,  62  ((20)): (1909-1910).  [PMID:23933538]
70. Nicholas A Dillon,Nicholas D Peterson,Brandon C Rosen,Anthony D Baughn.  (2014-09-24)  Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide..  Antimicrobial agents and chemotherapy,  58  ((12)): (7258-7263).  [PMID:25246400]
71. Archana Kumari,Pawan K Jewaria,Dominique C Bergmann,Tatsuo Kakimoto.  (2014-11-09)  Arabidopsis reduces growth under osmotic stress by decreasing SPEECHLESS protein..  Plant & cell physiology,  55  ((12)): (2037-2046).  [PMID:25381317]
72. Sudhir Chowdhry,Ciro Zanca,Utkrisht Rajkumar,Tomoyuki Koga,Yarui Diao,Ramya Raviram,Feng Liu,Kristen Turner,Huijun Yang,Elizabeth Brunk,Junfeng Bi,Frank Furnari,Vineet Bafna,Bing Ren,Paul S Mischel.  (2019-04-26)  NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling..  Nature,  569  ((7757)): (570-575).  [PMID:31019297]
73. Zhichao Liu,Qiang Shi,Don Ding,Reagan Kelly,Hong Fang,Weida Tong.  (2011-12-24)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)..  PLoS computational biology,  ((12)): (e1002310-e1002310).  [PMID:22194678]

Solution Calculators